Indian Health Search Portal Practo Lands $90M Led By Tencent For Global Expansion
Chinese internet giant Tencent is getting its tentacles into India's healthcare space after it lead a $90 million Series C round for medical search startup Practo. The startup raised $30 million in February …
Context & Ripple Effects
Tencent's $90 million Series C for Practo comes just months after the health-search startup's $30 million February raise, and it is a bet Tencent would repeat: by January 2017 the firm was back leading Practo's $55 million Series D as the company pushed beyond India into more markets.
The deal slots into a wider pattern of Chinese capital wiring up Asian digital health — Tencent's portfolio play on the consumer side mirrors what its own holding WeDoctor would later do at scale, and its appetite for Indian consumer platforms extended well beyond medicine.
First-order effects
- Practo gets the capital to execute its stated global expansion, moving from an India-focused medical search portal toward international markets while Sequoia-backed competitors face a better-funded rival.
- Tencent secures a lead position in Indian healthcare search, extending its China-centric health investments into a second geography.
Second-order effects
- Rival health platforms in India now compete against a Tencent-backed player whose funding cadence ($30M in February, $90M by August) signals follow-on support, pressuring them to seek comparable strategic investors rather than purely financial capital.
- Tencent's playbook of pairing platform stakes with ecosystem bets extends across adjacent verticals — it later took a 10% stake in insurance aggregator Policybazaar at a $1.5B valuation, showing the same consumer-finance-adjacent logic applied to Indian internet assets.
Third-order effects
- If the pattern holds, Asian digital-health consolidation runs through a small set of Chinese strategic investors — Tencent's backing of both Practo in India and WeDoctor's $500M raise at a $5.5B valuation in China points to regional networks rather than country-by-country competition, a structure that later drew large-scale capital into the sector (Indian health tech startups alone raised $3.7B since 2022).
- Strategic-led rounds like this reshape exit paths for Indian health startups: acquisition candidates such as 1mg, majority-acquired by Tata Digital become the template where corporate consolidators, not public markets, absorb funded challengers.
The trend: Chinese strategic capital, with Tencent in the lead, has been building cross-border positions across Asian digital health — turning national health-search portals into pieces of a regionally connected investment network.